☰

Dong-Joo (Ellen) Cheon - Publications

Affiliations: 
Albany Medical Center, Albany, NY, United States 
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Rada M, Eldred C, Sage J, Orsulic S, Cheon D. Abstract TMEM-017: COLLAGEN TYPE XI ALPHA 1 (COL11A1) IS A NOVEL STROMAL MEDIATOR OF CHEMORESISTANCE Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Tmem-017  0.767
2017 Rada M, Cha J, Sage J, Orsulic S, Cheon D. Abstract 2975: Collagen type XI alpha 1 confers cisplatin chemoresistance in ovarian cancer through inhibitor of apoptosis proteins (IAPs) Cancer Research. 77: 2975-2975. DOI: 10.1158/1538-7445.Am2017-2975  0.723
2015 Beach JA, Aspuria P, Cheon D, Gozo MC, Karlan BY, Orsulic S. Abstract B09: Sphingosine kinase 1 (SPHK1) is a novel mediator of tumor-stroma interaction in ovarian cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B09  0.727
2015 Cheon D, Beach J, Walts A, Karlan B, Orsulic S. Abstract A39: COL11A1 is a regulator of tumor microenvironment and a biomarker of metastatic progression Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A39  0.737
2014 Taylor-Harding B, Agadjanian H, Aspuria P, Cheon D, Mizuno T, Greenberg D, Allen JR, Orsulic S, Walsh C, Karlan BY, Wiedemeyer WR. Abstract 678: The Ets factor ETV5 regulates E2F target genes and mediates drug resistance Cancer Research. 74: 678-678. DOI: 10.1158/1538-7445.Am2014-678  0.692
2014 Li A, Cheon D, Karlan B, Orsulic S. The prognostic significance of ADAM metallopeptidase domain 12 in advanced stage serous ovarian cancer Gynecologic Oncology. 135: 386. DOI: 10.1016/J.Ygyno.2014.07.018  0.639
2013 Agadjanian H, Cheon D, Diaz E, Laury A, Miller C, Karlan B, Orsulic S, Walsh C. Abstract 329: A mouse model of epithelial ovarian cancer with defined oncogenic drivers. Cancer Research. 73: 329-329. DOI: 10.1158/1538-7445.Am2013-329  0.641
2013 Cheon D, Tong Y, Sim M, Cui X, Berel D, Tighiouart M, Wiedemeyer WR, Karlan B, Orsulic S. Abstract 1511: Stromal gene signature regulated by TGFβ signaling predicts poor clinical outcome in ovarian cancer . Cancer Research. 73: 1511-1511. DOI: 10.1158/1538-7445.Am2013-1511  0.719
2013 Aspuria P, Cheon D, Gozo M, Salumbides B, Vergnes L, Asara J, Reue K, Kensicki E, Karlan B, Orsulic S. Abstract 1088: HOXB13 inhibition of succinate dehydrogenase leads to epithelial-to-mesenchymal transition in mouse ovarian cancer cell lines. Cancer Research. 73: 1088-1088. DOI: 10.1158/1538-7445.Am2013-1088  0.726
2013 Cheon D, Beach J, Tong Y, Cui X, Tighiouart M, Liu Z, Walts AE, Karlan BY, Orsulic S. Abstract IA11: Using publicly available databases for the functional characterization of cancer genes Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-Ia11  0.737
2013 Taylor-Harding B, Agadjanian H, Aspuria PJ, Mizuno T, Cheon D, Orsulic S, Karlan B, Walsh C, Wiedemeyer WR. Abstract B48: Targeting chemo-resistance in CCNE1-amplified ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B48  0.736
Show low-probability matches.